Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Infectious proctitis: when to suspect it is not inflammatory bowel disease.
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors.
Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.
Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest. 2015 Feb; 125(2):769-81.
View in:
PubMed
subject areas
Animals
Gene Deletion
Gene Expression Regulation, Enzymologic
Humans
Hypothalamo-Hypophyseal System
Hypothyroidism
Intracellular Signaling Peptides and Proteins
Iodide Peroxidase
Mice
Mice, Knockout
Rats
Thyrotropin
Thyroxine
Ubiquitination
Ubiquitin-Protein Ligases
authors with profiles
Antonio Bianco